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Objective: Several studies have found an increased fall risk in persons with osteoarthritis (OA). However, most
prospective studies did not use a clinical definition of OA. In addition, it is not clear which factors explain this
risk. Our objectives were: (1) to confirm the prospective association between clinical OA of the hip and knee
and falls; (2) to examine the modifying effect of sex; and (3) to examine whether low physical performance,
low physical activity and use of pain medication are mediating these relationships.
Methods: Baseline and 1-year follow-up data from the European Project on OSteoArthritis (EPOSA) were used
involving pre-harmonized data from five European population-based cohort studies (ages 6585, n = 2535).
Clinical OA was defined according to American College of Rheumatology (ACR) criteria. Falls were assessed
using self-report.
Results: Over the follow-up period, 27.7% of the participants fell once or more (defined as faller), and 9.8% fell
twice or more (recurrent faller). After adjustment for confounding, clinical knee OA was associated with the
risk of becoming a recurrent faller (relative risk=1.55; 95% confidence interval: 1.102.18), but not with the
risk of becoming a faller. No associations between clinical hip OA and (recurrent) falls were observed after
adjustment for confounding. Use of opioids and analgesics mediated the associations between clinical OA
and (recurrent) falls, while physical performance and physical activity did not.
Conclusion: Individuals with clinical knee OA were at increased risk for recurrent falls. This relationship was
mediated by pain medication, particularly opioids. The fall risk needs to be considered when discussing the
risk benefit ratio of prescribing these medications.
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About one in three persons aged 65 years and older experience a
fall in a year, and about 15% fall twice or more [13]. Because of
physiological changes during aging acting on sensorimotor and cog-
nitive aspects, the incidence of falls increases with age [4,5]. In addi-
tion to soft-tissue injuries, falls may lead to more serious injuries,
such as fractures and head trauma [6,7]. Falls may also lead to fear of
falling, decreased physical function, restriction of physical activities,
loss of independence, a higher mortality risk and high health care
costs [4,6,811]. According to the American College of Rheumatology
(ACR), clinical osteoarthritis (OA) is defined by pain in combination
with other symptoms, such as stiffness [12]. As a consequence of
these symptoms, persons with OA may have impaired physical func-
tion and consequently, an increased fall risk.
Several prospective studies have shown an association between
OA and falls. Women with radiographic hip OA had a reduced risk for
recurrent falls, while women with self-reported, physician-diagnosed
OA had an increased risk [13]. In another study, postmenopausal
women with self-reported, physician-diagnosed OA had an increased
risk for falls [14]. An increasing number of lower-extremity symp-
tomatic OA joints [15], i.e. a combination of patient-reported symp-
toms and radiographic evidence of OA in the same joint, and early
diagnosed clinical hip and knee OA [16] were associated with an
increased odds for falling. Finally, radiographic knee OA in combina-
tion with symptoms of pain was associated with injurious falls in
men, but not in women [17]. Although most of these results pointed
in the same direction, different definitions of OA were used and not
all studies used a clinical definition. In an earlier study from our
group it was shown that clinical OA only partly overlaps with radio-
graphic OA and self-reported OA [18]. As the clinical symptoms, and
associated consequences, might induce the increased fall risk, it is
important to focus on a clinical definition of OA when studying the
association with falls. In addition, a clinical definition might be most
relevant for clinical practice. In the above studies, it is not clear
whether sex is an effect modifier in the relationship between OA and
falls as two studies were performed in women only, two studies
found an association in both men and women, and one study found
an association in men but not in women.
It is important to study by which mechanism clinical OA leads to
falls as this might give clues for prevention. In a previous report of
our European Project on OSteoArthritis (EPOSA), associations
between clinical OA of the hip and knee and decreased physical per-
formance were observed [19]. Components of physical performance,
such as impaired balance and muscle weakness were also identified
as risk factors for fall in clinical knee OA in a recent systematic review
[20]. In addition, clinical OA of the knee was shown to be associated
with lower physical activity levels [21]. Both low physical perfor-
mance and low physical activity might increase the risk of (recur-
rent) falls [2224]. However, up till now the mediating effects of
physical performance and physical activity have not been exam-
ined. Another potential mediator might be use of pain medica-
tion. Pain is one of the key symptoms in the definition of clinical
OA as proposed by the ACR [12]. Because of this pain, analgesics
are often prescribed to people with clinical OA [25], which may
lead to improvement of physical function. On the other hand, use
of analgesics, especially opioids [26], has been related to an
increased risk of falls, and therefore, the mediating effects of use
of analgesics and opioids will be examined.
To summarize, the first objective of our study was to confirm
whether a clinical diagnosis of hip and knee OA, according to the ACR
criteria, is related to an increased fall risk. The second objective was
to examine whether sex is an effect modifier in this relationship. The
third objective was to examine the potentially mediating effects of
physical functioning, physical activity, and use of analgesics and
opioids. The study was performed using data of the EPOSA study, aprospective, population-based cohort study in community-dwelling
older men and women from different European countries.
Materials and methods
Design and participants
Baseline and follow-up data were used from the EPOSA study,
which is a European study focusing on the personal and societal bur-
den of OA, and its determinants, in older persons. A detailed descrip-
tion of the study design and data collection of the EPOSA study has
been published previously [27]. In summary, random samples were
taken from five existing population-based cohorts from Germany
(GER), the Netherlands (NL), Spain (ES), Sweden (SWE), and the
United Kingdom (UK). In Italy (IT), a new sample was drawn. Out of
4040 persons who were invited, a total of 2942 participants partici-
pated (response rate 72.8%, for more details [27]). The age-range was
between 65 and 85 years in most countries except for the UK, which
had an age-range of 7179 years. There were no further inclusion or
exclusion criteria.
For the current sub-study, German participants were excluded
from the analyses as no data on fall rate were available (n = 407) leav-
ing 2535 participants for the analyses. Data collection started from
November 2010 to March 2011 in all countries. All participants were
interviewed at baseline and after 1218 months of follow-up by a
trained researcher at home or in a clinical center, using a standard-
ized questionnaire and a clinical exam. An English version of the
questionnaire was developed during a workshop with all EPOSA part-
ners at the start of the project. The questionnaire was translated (and
retranslated) into different languages. In addition, a rheumatologist
(M.H. Edwards, UK) visited all sites, together with one of the
researchers (S. van der Pas, NL). The rheumatologist gave trainings to
prospective interviewers to ensure that the clinical exam of the OA
measurement was performed in a standardized way in all countries.
He also made a videotape showing how the clinical exam should be
performed. The researcher trained the questionnaire and other clinical
measurements. For all five countries, the study design and procedures
were approved by the Medical Ethics committees of each site (NL:
Medisch Ethische Toetsingscommissie Vrije Universiteit Amsterdam
[2002/141]; ES: Comite Etico de Investigacion Clínica del Hospital Uni-
versitario La Paz Madrid [PI-1080]; SWE: Till forskningsetikkommitten
vid Karolinska Instituted Stockholm [00132]; UK: Hertfordshire
Research Ethics Committee [10/H0311/59]; Italy: Comitato Etico Pro-
vinciale Treviso[ XLIV-RSA/AULSS7]), and research was performed in
compliance with the Helsinki Declaration. All participants provided
written informed consent.
Independent variables
Independent variables include: clinical hip OA and clinical knee
OA. Diagnoses of clinical hip OA and knee OA were based on both
self-report and physical examination using algorithms based on the
ACR clinical classification criteria [12]. Clinical hip OA was defined as:
pain in the hip as evaluated by the Western Ontario and McMaster
Universities OA Index (WOMAC) pain subscale score (score of 3 or
higher out of 20), plus all of: pain associated with hip internal rota-
tion in at least one side; morning stiffness lasting <60 min evaluated
by the WOMAC stiffness subscale (score from ‘mild’ to ‘extreme’);
and over 50 years of age [28,29]. Clinical knee OA was defined as:
pain in the knee as evaluated by the WOMAC pain subscale score
(score of 3 or higher out of 20), plus any 3 of: morning stiffness last-
ing <30 min evaluated by the WOMAC stiffness subscale (score from
‘mild’ to ‘extreme’); crepitus on active motion in at least one side;
bony tenderness in at least one side; bony enlargement in at least
one side, no palpable warmth of synovium in both knees; and over
50 years of age. For more details, see design paper [27].
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Falls were assessed at follow-up using 2 questions: (1) Did you fall
in the past year? (2) If yes, how often did you fall in the past year?.
Two dichotomous outcomes were defined: fallers (1 or more falls)
versus no fallers (0 falls); recurrent fallers (2 or more falls) versus no
recurrent fallers (01 falls); and one trichotomous outcome: 2 or
more falls, 1 fall, 0 falls.
Potential effect modifier
Sex was examined as a potential effect modifier.
Potential confounders
Potential confounders were selected based on earlier studies on
OA and fall risk and on studies examining risk factors for falls in the
general population or in persons with OA: age [13,15,17,30], sex (if
no effect modifier) [15,17], country, level of education [17,31], body
mass index (BMI) [15,17,31], smoking [17], alcohol use [31], and
number of chronic diseases [17,20]. All confounders were assessed at
baseline. Information on age and sex were derived from the existing
cohort data. Educational level was assessed by the highest level of
education completed. Because of country differences in the distribu-
tion of educational level [32], educational level was dichotomized
into elementary school (not) completed versus vocational education/
general secondary education or higher. BMI was calculated as mea-
sured weight in kilograms divided by measured height in meters
squared. Smoking (never, former, current) and current alcohol use
(no/yes) were assessed by self-report. Number of chronic diseases
was assessed by self-report of the presence of chronic non-specific
lung disease, cardiovascular diseases, peripheral artery diseases,
stroke, diabetes, cancer, and osteoporosis. The number of chronic dis-
eases was categorized into 0, 1, 2 or more chronic diseases.
Potential mediators
Potential mediators were physical performance, physical activity,
analgesics use and opioids use. Physical performance was assessed
using three tests of walking speed, repeated chair stands and stand-
ing balance based on the methods described by Guralnik et al.
[19,33]. Total score ranges from 0 to 12 with 12 indicating good per-
formance. Physical activity was assessed using the validated LASA
Physical Activity Questionnaire (LAPAQ) [34] and reported in
minutes/day. Current use of analgesics (yes/no) and current use of
opioids (yes/no) were assessed by self-report. Participants were
asked to show which medications, prescribed by a doctor, they had
used during the past two weeks. The Anatomical Therapeutic Chemi-
cal (ATC) Classification was used to define use of analgesics (NO2)
and opioids (NO2A, NO2BE51). Nonsteroidal anti-inflammatory drugs
(NSAIDs, M01) were not included as the effect estimate of NSAIDs on
falls was small and non-significant in a recent meta-analysis (pooled
OR=1.09; 95% CI: 0.961.23) [26].
Statistical analyses
First, baseline tables were created in which fallers (1 or more falls)
were compared with no fallers (0 falls); and recurrent fallers (2 or
more falls) were compared with no recurrent fallers (01 falls).
Mean differences were tested using Student’s t-tests for normally dis-
tributed variables; differences in frequencies were tested using Pear-
son Chi-square Tests. Second, the prevalence of clinical hip and knee
OA and the prevalence of (recurrent) falls were calculated for the
total population. In the descriptive analyses, sample weights were
used to adjust for differences in age and sex distribution across coun-
try samples [27].Before proceeding with the multivariable analyses, multiple
imputation of missing values was performed using the Multivariate
Imputation by Chained Equations (MICE) procedure using all varia-
bles included in the models [35]. Based on the percentage of partici-
pants with missing data on at least one variable (25%), we created 25
different imputed data sets [36]. Based on evaluation of the missing
data patterns and reasons for non-response, it was assumed that the
data fulfilled the missing at random (MAR) assumption. Rubin’s rules
were applied for pooling estimates across the imputed datasets [37].
Cox Proportional Hazards Model with equal survival time for all
subjects was used to examine the association between clinical OA of
the hip and knee, respectively, and the risk of becoming a faller or
recurrent faller. By using equal survival time for all subjects, Cox Pro-
portional Hazards Model generates a relative risk instead of an odds
ratio. As the prevalence of falls is relatively high, an odds ratio would
be an overestimation of the true effect. As a first step, it was tested
whether sex was an effect modifier in a model including age, sex and
country (P<0.10). In case of an interaction effect, the analyses were
stratified on sex. As a second step, potential confounders were added.
In the first model, the analyses were adjusted for age, sex (if no inter-
action effect was present) and level of education. In the second
model, the analyses were adjusted for body mass index, smoking,
alcohol use, and number of chronic diseases. To check validity of the
multiple imputation procedure, we also performed the above analy-
ses as complete case analyses. As a sensitivity analysis, the associa-
tions between clinical OA of the hip and knee, respectively, and
number of falls (0, 1, 2 or more falls, 0 falls=reference group) were
analyzed using multinomial regression analyses.
Next, potentially mediating effects of physical performance, phys-
ical activity, analgesics use and opioids use were examined by
decomposing the total effect of clinical OA on (recurrent) falls into a
direct and indirect effect. The direct effect is the effect of clinical OA
on (recurrent) falls after adjustment for the mediator. The indirect
effect was estimated as the multiplication of the effect of clinical OA
on the mediator and the effect of the mediator on (recurrent) falls
after adjustment for clinical OA [38]. The indirect effect quantifies the
effect of OA on recurrent (falls) that is channeled through the poten-
tial mediator. In case the indirect effect is statistically significant
(p<0.05), the total effect is considered to be mediated by the poten-
tial mediator. Mediation analyses were performed irrespective of the
presence of a significant total effect, as the absence of a significant
total effect does not necessarily imply the absence of a direct and
indirect effect [39]. When performing mediation analyses it is highly
important to carefully choose the adequate time lags between the
measurements of the exposure, mediator and outcome, as poorly
chosen time lags can be a poor representation of the mediated effects
[40]. In our study, we made the assumption that the clinical diagnosis
was made prior to the measurement of the mediators and that the
outcome was measured after the mediators. In the analyses, the
determinant and mediator (a-path) were chosen at baseline, as we
know that clinical OA of the hip and knee are characterized by pain
and stiffness, which might directly influence physical performance
and physical activity. In addition, because pain is a key feature, pain
medication is often prescribed immediately after the diagnosis. Falls
were assessed during 12 to 18 months of follow-up. Thus, by design,
the outcome (falls) takes place after the mediator (b-path). Multivari-
able regression analyses were performed for continuous outcomes,
and Cox Proportional Hazards Model with equal survival time for all
subjects for dichotomous outcomes [41,42]. All mediation analyses
were adjusted for the complete set of confounding variables. Since
the indirect effect usually has a skewed distribution, Monte Carlo 95%
confidence intervals using 20,000 replications were estimated for the
indirect effect [43]. All analyses were performed in IBM SPSS Statis-
tics version 22, except for the 95% confidence interval around the
indirect effect, which was calculated using R statistical software ver-
sion 3.1.1.
Table 2
Associations between clinical OA of the hip or knee and (recurrent)
falls.
RR (95% CI)




- Model 1 1.35 (1.001.82)* 1.48 (0.932.38)
- Model 2 1.34 (0.991.81) 1.47 (0.912.38)
Clinical knee OA
- Model 1 1.13 (0.931.39) 1.57 (1.132.18)*
- Model 2 1.10 (0.901.36) 1.55 (1.102.18)*
RR=relative risk; 95% CI: 95% confidence interval;
OA=osteoarthritis.
*= p<0.05
The analyses were performed using Cox Proportional Hazards
Model with equal survival time for all subjects. Model 1: Adjusted
for age, sex, country and level of education. Model 2: Additionally
adjusted for body mass index, smoking, alcohol use, number of
chronic diseases.
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In Table 1, baseline characteristics are presented for fallers (1 or
more falls) versus non-fallers (0 falls), and for recurrent fallers (2 or
more falls) versus non-recurrent fallers (01 falls). Both fallers and
recurrent fallers were significantly older, more often female, more
often never smokers, had more often 2 or more chronic diseases,
lower physical performance scores and were more often users of
analgesics and opioids as compared with no (recurrent) fallers. In
addition, recurrent fallers were less often alcohol users as compared
with no recurrent fallers.
In the total sample, 6.7% had clinical hip OA and 22.1% had clinical
knee OA according to the ACR criteria. During follow-up, 27.7%
reported a fall (classified as faller) and 9.8% reported two or more falls
(classified as recurrent faller).
In Table 2, the associations between clinical hip OA and clinical
knee OA, respectively, with falls and recurrent falls are presented.
Sex was not an effect modifier of these associations (p-value for inter-
action  0.49). Although most associations pointed in the same direc-
tion, only the association between clinical knee OA and recurrent
falls was statistically significant after adjustment for confounding
(RR=1.55; 95% CI: 1.102.18 in the fully adjusted model). Similar
results were observed in the complete case analyses (data not
shown), and when analyzing the outcome number of falls in three
categories (0, 1, 2 or more falls) using multinomial regression analy-
ses. A statistically significant association was observed only between
clinical knee OA and the risk of 2 or more falls versus 0 falls
(OR=1.49; 95% CI: 1.102.38), but not for 1 fall versus 0 falls. No sig-
nificant associations were observed for clinical hip OA in the multino-
mial regression analyses (data not shown).
In Table 3, it can be seen that use of opioids mediated the associa-
tions between hip OA and recurrent falls, and between knee OA and
recurrent falls. In addition, use of analgesics mediated the associa-
tions between knee OA and (recurrent) falls. Clinical hip and knee OA
were significantly related to lower physical performance, but physi-
cal performance was not significantly related to (recurrent) falls. Clin-
ical knee OA was significantly related to lower physical activity, butTable 1






Agea 74.9 (6.2) 73.9 (5.9) 0.002
Sex (female)b 63.6% 54.0% <0.001
Educational levelb
- Elementary school completed or lower
- Vocational education or general sec-


















Alcohol use (yes)b 70.0% 73.7% 0.098
Nr. of chronic diseasesb
- 0
- 1








Physical performancea, c 8.1 (2.9) 8.5 (2.5) 0.002










a Differences in mean were tested using independent Student’s t-test.
b Differences in frequencies were tested using Pearson Chi-square Test.
c Total score ranges from 012 with 12 indicating good performance.
d LN-transformed data were used in the Student’s t-test; in the Table thesephysical activity was not significantly related to (recurrent) falls. The
indirect effects through physical performance and physical activity
were not statistically significant, indicating that the effect of clinical
OA on (recurrent) falls was not mediated by physical performance
and physical activity.
Discussion
In this study, individuals aged 6585 years with clinical knee OA
had a 1.5 times higher risk to become a recurrent faller in the follow-
ing year as compared with persons without clinical knee OA. This
association was similar for men and women. Use of opioids and use
of analgesics were mediators, while physical performance and physi-
cal activity were not. No statistically significant associations between
clinical hip OA and (recurrent) falls were observed after adjustment
for confounding.
Our results are partly in line with earlier prospective studies that






P-value Nr of missings per
variable in total
population (n = 2535)
76.0 (6.0) 74.0 (6.0) <0.001 0






















7.6 (3.1) 8.5 (2.6) <0.001 107









data were back transformed.
Table 3
Mediation analyses: physical performance, physical activity, analgesics use and opioids use as potential mediators (M) in the association between clinical OA of
the hip and knee (Determinant, D) and falls (Outcome, O).
Clinical OA (D) Mediating variable (M) Outcome
(O)
Effect of D on M
(a-path)









Hip OA Physical performance Falls 1.440* 0.024 0.255 0.100 0.035 (0.013; 0.086)
LN (Physical activity) Falls 0.054 0.014 0.288 0.061 0.001 (0.009; 0.012)
Analgesics use Falls 0.184 0.272* 0.280 0.068 0.050 (0.049; 0.183)
Opioids use Falls 1.111* 0.285 0.256 0.095 0.317 (0.062; 0.760)
Hip OA Physical performance Recurrent falls 1.440* 0.053 0.306 0.219 0.076 (0.004; 0.166)
LN (Physical activity) Recurrent falls 0.054 0.044 0.379 0.124 0.002 (0.013; 0.023)
Analgesics use Recurrent falls 0.184 0.417* 0.364 0.139 0.077 (0.075; 0.283)
Opioids use Recurrent falls 1.111* 0.585* 0.309 0.211 0.650 (0.088; 1.353)*
Knee OA Physical performance Falls 1.035* 0.026 0.072 0.498 0.027 (0.007; 0.064)
LN (Physical activity) Falls 0.096* 0.013 0.097 0.358 0.001 (0.011; 0.014)
Analgesics use Falls 0.378* 0.269* 0.076 0.470 0.102 (0.016; 0.217)*
Opioids use Falls 0.913* 0.308 0.077 0.472 0.281 (0.033; 0.657)
Knee OA Physical performance Recurrent falls 1.035* 0.047 0.385 0.029* 0.049 (0.009; 0.117)
LN (Physical activity) Recurrent falls 0.096* 0.032 0.431 0.014* 0.003 (0.016; 0.024)
Analgesics use Recurrent falls 0.378* 0.381* 0.398 0.023* 0.144 (0.015; 0.322)*
Opioids use Recurrent falls 0.913* 0.539* 0.391 0.026* 0.492 (0.032; 1.073)*
Analyses were performed using multivariable regression analyses for continuous outcomes and Cox proportional hazards model with equal survival time for all
subjects for dichotomous outcomes. Presented are the Beta’s unless stated otherwise. All analyses were adjusted for age, sex, country, level of education, body
mass index, smoking, alcohol use, number of chronic diseases. The b-path was additionally adjusted for clinical OA. The c’-path was additionally adjusted for the
potential mediator.
* p<0.05.
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OA, and of clinical knee and hip OA, respectively, observed associa-
tions with one or more falls [15,16]. In the first study, recurrent fall-
ing was examined in a sensitivity analysis showing similar results as
the results on falls [15]; in the second study, a higher cumulative
number of falls was observed in people with early diagnosed hip or
knee OA [16]. In our study, we only observed an association of clinical
knee OA with recurrent falling, and not with falling. Although the
estimates for the association with falling pointed in the same direc-
tion, they were weaker. It may be that an association with recurrent
falls is easier to detect as a single fall may be coincidental, while
recurrent falls are more likely to have an internal, disease-related
cause. Another difference is that the second study also found an asso-
ciation between clinical hip OA and falls, while we only found a sta-
tistically significant association in the model adjusted for age, sex,
country and level of education but not in the fully adjusted model.
However, also in the fully adjusted model, estimates pointed in the
same direction. Because of the relatively low prevalence of hip OA in
our representative sample of community-dwelling older people,
power may have been too low to detect a statistically significant dif-
ference.
Two other studies examined self-reported, physician-diagnosed
OA in women, without specification of the site of OA. In these studies,
an increased risk for recurrent falling [13] and falling [14] was
observed. Interestingly, in the SOF study, women with radiographic
hip OA had a reduced risk for recurrent falls [13]. The associations in
the SOF study were not explained by factors known to be associated
with falls [13]. It is not clear whether the contradicting results
between self-reported and radiographic OA in these studies can be
explained by the difference in site (non-specified self-reported OA
versus radiographic hip OA), or that OA is only related to falls in the
presence of clinical symptoms.
The associations between clinical OA and (recurrent) falls were
mediated by pain medication in our study, while physical perfor-
mance and physical activity were not mediators. In an earlier study
performed in persons with or at risk for knee OA, opioid use was
related to an increased risk for recurrent falls [44], which is in line
with our study. In that study, also persons using antidepressants had
an increased risk for recurrent falls. Differences with our study were
that all participants had symptomatic knee OA or were at risk for
knee OA, the study sample was younger (4579 years), and that
medication use was analyzed as a determinant and not as a mediator.Besides pain medication, several other factors may contribute to the
increased risk for recurrent falls in persons with clinical knee OA. In a
review, the role of neuromuscular changes on dynamic postural control
were discussed [45]. The authors conclude that greater neuromuscular
deficits are seen in musculoskeletal conditions such as OA as compared
with normal aging. Neuromuscular changes in OA affecting dynamic
postural control include joint pain, reduced proprioception, muscle
weakness and diminished muscle power [45]. More advanced mobility
measures than our physical performance tests may show a mediating
effect of neuromuscular changes in the relationship between clinical
OA and falls, andmay be worthwhile to study in future research.
In our study, 6.5% of participants used opioids and 22.3% used
analgesics (including opioids). The mediating effects of opioids alone
were larger than those of analgesics. In a recent randomized con-
trolled trial, patients with moderate to severe back pain or hip or
knee OA pain, the use of opioid vs non-opioid medication therapy did
not result in significantly better pain-related function over 12
months. The authors conclude that their results do not support initia-
tion of opioid therapy for moderate to severe chronic back pain or
hip or knee osteoarthritis pain [46]. In addition, a recent meta-analy-
sis concluded that oral opioids were associated with an increased risk
of adverse events of the gastrointestinal, dermatologic and central
nervous system [47]. They recommend to follow the treatment algo-
rithm of the taskforce of the European Society for Clinical and Eco-
nomic Aspects of Osteoporosis and Osteoarthritis (ESCEO), which
recommends that opioids should only be used as a step 3 treatment
in case of severely symptomatic OA, and preferably for short periods
of time [47,48], which we fully agree with. It should be noted that
when patients are already using opioids, one should be very careful
in stopping this medication, as pain itself might also increase the fall
risk (e.g. [49]) and stopping opioids might have other undesirable
consequences. Based on our results and the above trial, one might
consider lowering the dose and/or replacing opioid by non-opioid
medication therapy while closely monitoring pain levels. In addition,
one might discuss alternative therapies for relieving pain together
with the patient, such as physiotherapy and weight loss. For example,
in a Cochrane review it was concluded that land-based therapeutic
exercise in knee OA provides short term benefit in terms of reduced
pain (high quality evidence) [50]. Finally, other fall prevention strate-
gies that have proven to be successful in persons at risk for falls, such
as multifactorial interventions and exercise [51] should be studied in,
and adapted for persons with OA.
N.M. van Schoor et al. / Seminars in Arthritis and Rheumatism 50 (2020) 380386 385Strengths of this study are the clinical definition of hip and knee
OA according to the ACR criteria; the prospective design of the EPOSA
study; the ability to study different mediators; and the large repre-
sentative sample from five different European countries. It should be
noted that although our clinical definition of hip and knee OA was
based on the ACR clinical classification criteria, some misclassification
might have occurred. Another weakness may be the retrospective
self-report of falls as compared to using prospective diaries. Previous
research has shown that sensitivity lies between 80 and 89% and
specificity between 91 and 95% for the recall of falls in the previous
year [52], indicating that some misclassification might have occurred.
This may especially be true for persons having cognitive deficits. In
addition, it was not possible to adjust for pain as it was highly corre-
lated with our definition of clinical OA. Therefore, we cannot exclude
that pain itself is a mediator in the relationship between clinical OA
and falls. Finally, because of the low prevalence of hip OA, we might
have had too low power to detect an association here.
In conclusion, this study highlights the risk of recurrent falls in
patients with clinical knee OA. This relationship was mediated by the
use of pain medication, particularly opioids. This needs to be consid-
ered when discussing the risk benefit ratio of prescribing these medi-
cations. In addition, other mechanisms leading to an increased fall
risk in persons with clinical knee OA, such as neuromuscular changes
and pain, should be studied in future research.Declarations of Competing Interest
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